← SynDRA
UNC-1999
SynDRA canonical compound SYN0051496 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | EZH1 | EZH2 |
|---|
| Mechanism of action | histone lysine methyltransferase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- EZH2 INHIBITOR
- histone lysine methyltransferase inhibitor
Cross-references
Synonyms
- UNC1999
- Unc1999
- RefChem:823123
- UNC 1999
- MFCD26960958
- GTPL8237
- orb1304582
- SCHEMBL16767552
- SCHEMBL29351394
- EX-A252
- CHEBI:230504
- C33H43N7O2
- GLXC-03428
- HMS3653O13
- UNC-1999?
- AKOS025142028
- CCG-270094
- CS-1658
- SB19347
- NCGC00351477-01
- NCGC00351477-09
- NCGC00351477-12
- AC-31433
- AS-55989
- DA-44779
- HY-15646
- UNC1999, >=98% (HPLC)
- S7165
- SW219705-1
- F869955
- BRD-K26989966-001-03-5
- BRD-K26989966-001-04-3
- N-[(1,2-Dihydro-6-methyl-2-oxo-4-propyl-3-pyridinyl)methyl]-1-(1-methylethyl)-6-[6-[4-(1-methylethyl)-1-piperazinyl]-3-pyridinyl]-1H-indazole-4-carboxamide
Look up UNC-1999 in the interactive SynDRA portal →